Private equity firm Clearlake Capital Group has acquired medical software company ProVation Medical Inc. from Wolters Kluwer.
Executives at Santa Monica, California-based Clearlake say they plan to build on ProVation Medical as a platform company, growing it both organically and through acquisitions. ProVation, based in Minneapolis, provides software for documenting medical procedures, improving clinical productivity and reimbursement, managing electronic health records and documenting surgeries. The company’s customers include 1,500 hospitals, 1,000 ambulatory surgery centers and 16 of the top 20 hospitals for gastroenterology and gastrointestinal surgery in the U.S.
ProVation CEO David Del Toro is staying on, and he will join the company’s board of directors. Del Toro says Clearlake’s operational support and financial backing will help Provation as it grows. “Clearlake’s extensive software and carve-out investment experience will prove invaluable to ProVation in this exciting new chapter,” he says.
Paul Huber, vice president of Clearlake, says ProVation should continue to grow because its software delivers a return on investment to healthcare providers in improved clinical productivity, increased profitability, more accurate reimbursement and higher quality patient care. “We believe ProVation’s strong value proposition and customer-focused culture will continue to drive leading hospitals and ambulatory surgery centers to adopt the company’s technology.”
Clearlake Capital focuses on small and medium-sized companies in software and technology, industrials and energy, and consumer sectors. Based in Santa Monica, California, Clearlake is led by José Feliciano and Behdad Eghbali, who have together built a team of investment professionals with a blend of sector and product capabilities through a history of long-term strategic partnerships with management to transform and grow companies. The PE firm has managed more than $7 billion of institutional capital since its 2006 inception, and its senior investment principals have led or co-led more than 100 investments.
Clearlake’s operating advisors including Janet Dryer, CEO of Perforce Software and former CEO of HelpSystems; John Ferron, executive chairman of Ivanti and former CEO of Heat Software; Chris Larson, principal of Wolf Point Global; and Jeff Nachbor, CFO of ConvergeOne (NASDAQ: CVON) and a former senior vice president of finance at Cricket Communications.
Wolters Kluwer, based in the Netherlands, provides software and services in the areas of healthcare, tax and accounting, finance and legal services, and risk and compliance.
Clearlake recently sold two of its software companies, Syncsort and Vision Solutions, as a merged company to Centerbridge Partners for $1.26 billion. Other recent Clearlake deals have included acquiring Janus International Group, supplier of doors and hallway systems to storage unit operators, and launching a “better-for-you” food and beverage company, Disruptive Brands, through a partnership with Bill Moses, co-founder of Kevita Probiotic Drinks, which was acquired by PepsiCo Inc. (NYSE: PEP) in 2016.
Medical software M&A has been flourishing as companies vie for market share and growth opportunities with hospitals, medical offices and administrators. Recent deals have included Inovalon (Nasdaq: INOV), a cloud-based healthcare software provider, agreeing to buy healthcare SaaS tools developer Ability Network from Summit Partners for $1.2 billion. Also, TPG Capital backed Mediware Information Systems agreed to buy Kinnser Software Inc., provider of software for home health care and hospice care.